Variants of intensification of immunosuppressive therapy of rheumatoid arthritis

Variants of intensification of immunosuppressive therapy of rheumatoid arthritis

Objective. To assess influence of different treatment intensification regimens on clinico- laboratory parameters of activity and quality of life of pts with rheumatoid arthritis (RA). Material and methods. 40 RA pts of group 1 received pulse-therapy with methotrexate (MT) and dexamethasone (DM), 20p...

Full description

Bibliographic Details
Main Authors:	E A Vasiljeva, A L Maslyansky, E P Ilivanova, A L Grigorjeva, V M Trishin, V I Masurov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2007-04-01
Series:	Научно-практическая ревматология
Subjects:	rheumatoid arthritis methylprednisolone dexamethasone cyclophosphane methotrexate therapy intensification
Online Access:	https://rsp.mediar-press.net/rsp/article/view/968

Similar Items

Combination pulse therapy with methotrexate and dexamethasone in patients with early rheumatoid arthritis and poor prognostic factors: an open-label randomized trial
by: Aleksey Leonidovich Maslyansky, et al.
Published: (2013-04-01)

Submicroscopic сhanges in the thyroid gland of rats after the immunosuppression
by: Kashchenko S.A., et al.
Published: (2013-01-01)

Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide
by: Tania Caroline Monteiro de Castro, et al.

PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS
by: I R Kolosova, et al.
Published: (2001-10-01)

Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01)

Perspectives of using sodium alginate with different molecular weight in the complex cancer therapy
by: O. Y. Rybalkina, et al.
Published: (2014-09-01)

Relationship between methotrexate dose and clinical efficacy for treatment of rheumatoid arthritis
by: HE Longquan, et al.
Published: (2020-09-01)

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
by: Almalag H, et al.
Published: (2020-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

COMPARATIVE EFFICIENCY AND TOLERABILITY OF CURRENT THERAPIES FOR EARLY RHEUMATOID ARTHRITIS
by: E. V. Fedorenko, et al.
Published: (2015-04-01)

EFFECT OF STIMFORTE UPON MURINE MONONUCLEAR LEUKOCYTES AND LYMPHOID ORGANS DURING CYCLOPHOSPHAN TREATMENT
by: D. G. Maldov, et al.
Published: (2014-07-01)

NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE
by: Evgeniy L Nasonov, et al.
Published: (2014-03-01)

POSSIBILITY OF ANTIDESTRUCTIVE EFFECT OF LOW DOSES OF CORTICOSTEROIDS IN RHEUMATOID ARTHRITIS: PRELIMINARY INFORMATION
by: N A Grunina, et al.
Published: (2000-02-01)

Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats
by: Liu YZ, et al.
Published: (2015-08-01)

About molecular characteristic peripheral blood lymphocytes in pts with rheumatoid arthritis
by: I. R. Kolosova, et al.
Published: (2003-06-01)

Methotrexate intolerance in Rheumatoid Arthritis
by: Harjit Singh Nalwa, et al.
Published: (2023-03-01)

THE EXPERIENCE OF REMICADE USAGE IN THE TREATMENT OF RHEUMATOID ARTHRITIS PTS
by: N F Soroka, et al.
Published: (2002-06-01)

Patterns of Cytopenias Associated with Methotrexate Treated Rheumatoid Arthritis Patients
by: Mohsin Shakoor Malik, et al.
Published: (2023-04-01)

EARLY RHEUMATOID ARTHRITIS: CURRENT ASPECTS OF ITS DIAGNOSIS AND TREATMENT
by: Yu A Olyunin, et al.
Published: (2010-03-01)

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
by: M. Manara, et al.
Published: (2016-12-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

PROBLEMS OF RHEUMATOID ARTHRITIS IMMUNOPATHOLOGY: EVOLUTION OF THE DISEASE
by: E. L. Nasonov
Published: (2017-07-01)

LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS
by: D. E. Karateev, et al.
Published: (2017-12-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

Ovarial function in pts with systemic lupus erythematosus
by: S Sh Sliabanova, et al.
Published: (2004-06-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
by: G. I. Gridneva, et al.
Published: (2019-05-01)

The Effectiveness of Submucosal Administration of Methylprednisolone and Dexamethasone in Comparison to Placebo after Third Molar Surgery: A Double Blinded, Parallel Arm Randomized Clinical Trial
by: Kinza Ayub, et al.
Published: (2023-01-01)

Treatment of Methylprednisolone Allergy with Dexamethasone
by: Öner Özdemir, et al.
Published: (2017-06-01)

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis
by: Menon Vimala, et al.
Published: (2007-01-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karatee, et al.
Published: (2016-12-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2015-10-01)

THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS
by: D. E. Karateev, et al.
Published: (2014-12-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

Simultaneous thrombosis of multiple coronary arteries in a patient with rheumatoid arthritis
by: Arzu Kalayci, et al.
Published: (2016-06-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

Superficial Ulcerating Rheumatoid Necrobiosis Associated with Methotrexate Use in a Patient with Rheumatoid Arthritis
by: Austin Cusick, et al.
Published: (2020-09-01)